Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheng-Kuang Yang

Showing results (41-50 of 73) with videos related to

Pageof 8
Sort By:
Anticancer Research|October 3, 2014
First-line treatment result influence second-line regimen selection in targeted therapy for metastatic renal cell carcinomaJian-Ri Li, Cheng-Kuang Yang, Shian-Shiang Wang, et al.
Journal of Hypertension|December 2, 2016
Spironolactone and the risk of urinary tract cancer in patients with hypertension: a nationwide population-based retrospective case-control studyYa-Wen Chuang, Mei-Ching Yu, Shih-Ting Huang, et al.
Renal Failure|May 16, 2012
Interleukin-2 receptor antagonist does not decrease biopsy-proven acute rejection among adult Chinese kidney transplant recipientsYing-Chih Lo, Hao-Chung Ho, Ming-Ju Wu, et al.
Frontiers in Immunology|October 20, 2025
Temporal trends in malignancy incidence and outcomes among kidney transplantation recipients: a multi-center real-world evidence study using the TriNetX network (2000-2010 vs. 2010-2021)Gu-Shun Lai, Jian-Ri Li, Chuan-Shu Chen, et al.
Journal of the Chinese Medical Association : JCMA|May 16, 2023
Risk analysis of subsequent therapies after first-line chemotherapy in advanced testicular cancer patientsTsung-Han Yen, Shian-Shiang Wang, Cheng-Kuang Yang, et al.
Anticancer Research|September 9, 2018
Outcome of Patients with Metastatic Castration-resistant Prostate Cancer After PSA Progression with Abiraterone AcetateSheng-Chun Hung, Shian-Shiang Wang, Jian-Ri Li, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 25, 2012
Efficacy of a protocol including heparin ointment for treatment of multikinase inhibitor-induced hand-foot skin reactionsJian-ri Li, Chi-rei Yang, Chen-li Cheng, et al.
Diagnostics (Basel, Switzerland)|September 4, 2020
Impact of H19 Polymorphisms on Prostate Cancer Clinicopathologic CharacteristicsJu-Chuan Hu, Chia-Yen Lin, Shian-Shiang Wang, et al.
International Journal of Medical Sciences|June 16, 2023
<i>WWOX</i> Polymorphisms as Predictors of the Biochemical Recurrence of Localized Prostate Cancer after Radical ProstatectomyChia-Yen Lin, Chun-Li Wang, Shian-Shiang Wang, et al.
Journal of the Chinese Medical Association : JCMA|July 25, 2012
Five-year experience of peritoneal dialysis catheter placementJian-Ri Li, Cheng-Hsu Chen, Chen-Li Cheng, et al.
Pageof 8

Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
Anticancer Research|October 3, 2014
First-line treatment result influence second-line regimen selection in targeted therapy for metastatic renal cell carcinomaJian-Ri Li, Cheng-Kuang Yang, Shian-Shiang Wang, et al.
Journal of Hypertension|December 2, 2016
Spironolactone and the risk of urinary tract cancer in patients with hypertension: a nationwide population-based retrospective case-control studyYa-Wen Chuang, Mei-Ching Yu, Shih-Ting Huang, et al.
Renal Failure|May 16, 2012
Interleukin-2 receptor antagonist does not decrease biopsy-proven acute rejection among adult Chinese kidney transplant recipientsYing-Chih Lo, Hao-Chung Ho, Ming-Ju Wu, et al.
Frontiers in Immunology|October 20, 2025
Temporal trends in malignancy incidence and outcomes among kidney transplantation recipients: a multi-center real-world evidence study using the TriNetX network (2000-2010 vs. 2010-2021)Gu-Shun Lai, Jian-Ri Li, Chuan-Shu Chen, et al.
Journal of the Chinese Medical Association : JCMA|May 16, 2023
Risk analysis of subsequent therapies after first-line chemotherapy in advanced testicular cancer patientsTsung-Han Yen, Shian-Shiang Wang, Cheng-Kuang Yang, et al.
Anticancer Research|September 9, 2018
Outcome of Patients with Metastatic Castration-resistant Prostate Cancer After PSA Progression with Abiraterone AcetateSheng-Chun Hung, Shian-Shiang Wang, Jian-Ri Li, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 25, 2012
Efficacy of a protocol including heparin ointment for treatment of multikinase inhibitor-induced hand-foot skin reactionsJian-ri Li, Chi-rei Yang, Chen-li Cheng, et al.
Diagnostics (Basel, Switzerland)|September 4, 2020
Impact of H19 Polymorphisms on Prostate Cancer Clinicopathologic CharacteristicsJu-Chuan Hu, Chia-Yen Lin, Shian-Shiang Wang, et al.
International Journal of Medical Sciences|June 16, 2023
<i>WWOX</i> Polymorphisms as Predictors of the Biochemical Recurrence of Localized Prostate Cancer after Radical ProstatectomyChia-Yen Lin, Chun-Li Wang, Shian-Shiang Wang, et al.
Journal of the Chinese Medical Association : JCMA|July 25, 2012
Five-year experience of peritoneal dialysis catheter placementJian-Ri Li, Cheng-Hsu Chen, Chen-Li Cheng, et al.
Pageof 8